Tandem Diabetes Care, Inc.
TNDM
$22.72
-$0.41-1.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.77% | 5.46% | 2.74% | 2.17% | 8.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.77% | 5.46% | 2.74% | 2.17% | 8.46% |
| Cost of Revenue | -4.39% | -4.81% | -1.81% | -3.65% | 5.23% |
| Gross Profit | 15.04% | 15.52% | 6.35% | 7.73% | 11.58% |
| SG&A Expenses | 1.87% | 3.07% | 6.86% | 6.83% | 16.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.54% | -1.58% | -0.40% | -0.28% | 7.86% |
| Operating Income | 56.71% | 49.46% | 1,525.09% | 23.11% | -3.53% |
| Income Before Tax | 64.21% | 83.72% | 29,162.50% | -11.18% | -94.07% |
| Income Tax Expenses | 109.58% | -93.91% | 813.26% | -724.49% | -596.92% |
| Earnings from Continuing Operations | 59.60% | 84.38% | -178.01% | 8.97% | -70.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.60% | 84.38% | -178.01% | 8.97% | -70.05% |
| EBIT | 56.71% | 49.46% | 1,525.09% | 23.11% | -3.53% |
| EBITDA | 66.09% | 57.16% | 249.14% | 28.85% | -3.10% |
| EPS Basic | 60.75% | 84.83% | -176.32% | 11.81% | -64.84% |
| Normalized Basic EPS | 46.86% | 45.97% | 125.13% | 4.31% | -31.97% |
| EPS Diluted | 60.75% | 84.83% | -176.32% | 11.81% | -64.84% |
| Normalized Diluted EPS | 46.86% | 45.97% | 126.32% | 4.31% | -31.97% |
| Average Basic Shares Outstanding | 2.92% | 3.00% | 3.15% | 3.23% | 3.16% |
| Average Diluted Shares Outstanding | 2.92% | 3.00% | 2.81% | 3.23% | 3.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |